Zinc supplementation for the prevention of type 2 diabetes mellitus

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2007, Pages

  Beletate, Vânia ^a   El Dib, R P ^b   Atallah, A N ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

*Dietary supplements; Diabetes mellitus, type 2 *prevention control ; Humans; Zinc *administration dosage

Indexed keywords

GLUCOSE; INSULIN; LEPTIN; PLACEBO; ZINC;

ANTHROPOMETRY; CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID METABOLISM; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; SYSTEMATIC REVIEW; ZINC BLOOD LEVEL;

EID: 36048954488     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005525.pub2     Document Type: Review

References (29)

1. Marreiro 2002 {unpublished data only} Marreiro DN. The effect of zinc supplementation in insulin resistance in obesity women [Efeito da suplementação com zinco na resistência à insulina em mulheres obesas]. Tese de Doutorado - Faculdade de Ciências Farmacêuticas - USP, São Paulo, Brazil 2002:109p..
2. Marchesini 1998 Marchesini G, Bugianesi E, Ronchi M, Flamia R, Thomaseth K, Pacini G. Zinc supplementation improves glucose disposal in patients with cirrhosis. Metabolism Baltimore 1998;47:792-8.
3. ADA 1998 American Diabetes Association. Screening for Type 2 Diabetes. Diabetes Care 1998;22(supp1):S20-S23.
4. ADA 1999 American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1999;22(1):S5-S19.
5. Barbara B 2000 Barbara B, Kahn, Jeffrey S. Flier. Obesity and insulin resistance. The journal of Clinical Investigation 2000;106(4):473-81.
6. Bonora 1998 Bonora E, Kiechi E, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna RC, Muggeo M. Prevalence of Insulin Resistance in Metabolic Disorders. Diabetes 1998;47:1643-49.
7. Bonora 2000 Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 2000;23(1):57-63.
8. Chausmer 1998 Chausmer AB. Zinc, Insulin and Diabetes. Journal of the American College of Nutrition 1998;17(2):109-15.
9. Cohen 1960 Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960;20:37-46.
10. DeFronzo 1979 DeFronzo RA, Tobin JD, Andres R. Glucose Clamp technique: a method for quantifying insulin secretion and resistance. The American Journal of Physiology 1979; 237: E214-E223;237:E214-E223.
11. Haase 2005 Haase H, Maret W. Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants. Biometals 2005;18(4):333-8.
12. Higgins 2003 Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. British Medical Journal 2003;327:555-7.
13. Higgins 2005 Higgins JPT, Green S, editors. Assessment of study quality. Cochrane reviewers Handbook 4.2.5. Chichester, UK: Section 4[ updated may 2005], 2005.
14. Howard 1996 Howard G, O' Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, Bergman R. Insulin sensitivity and atherosclerosis: the insulin resistance atherosclerosis study (IRAS) Investigators. Circulation 1996;93:1809-17.
15. Juni 1999 Juni P, Witschi A, Bloch R, Egger M. The razards of scoring the quality of clinical trials for meta-analysis. The Journal of the American Medical Association 1999;288(11):1054-60.
16. Karelis 2004 Karelis AD, Henry JF, Malita F, ST-Pierre DH, Vigneault I, Poehlman ET, Rabasa-Lhoret R. Comparison of insulin sensitivity values using the hyperinsulinemic euglycemic clamp: 2 vs 3 hours. Diabetes & Metabolism 2004;30:413-14.
17. Marchesini 1998 Marchesini G, Bugianesi E, Ronchi M, Flamia R, Thomaseth K, Pacini G. Zinc Supplementation Improves Glucose Disposal in Patients With Cirrhosis. Metabolism: Clinical and Experimental 1998; 47(7):792-98.
18. Marreiro 2004 Marreiro, Dilina N, Geloneze, Bruno, Tambascia, Marcos A, Lerário, Antonio C, Halpern, Alfredo, Cozzolino, Silvia M. F. Participation of zinc in insulin resistance [Participaçäo do zinco na resistência à insulina]. Arquivos brasileiros de endocrinologia emetabologia 2004;48 (2):234-39.
19. Marreiro 2004b Marreiro DN, Geloneze B, Tambascia MA, Lerario AC, Halpern A, Cozzolino SM. Role of zinc in insulin resistance [Papel do zinco na resistência à insulina]. Arq Bras Endocrinol Metabol 2004;48(2):234-9.
20. Matthews 1985 Matthews DR, Hoster JP, Rudenski BA, Naylor DF, Treacher, RC. Turner. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-19.
21. Moher 1999 Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999;354(9193):1896-900.
22. Moro 2003 Moro E, Gallina P, Pais M, Cazzolato G, Alessandrini P, Bittolo-Bon G. Hypertriglyceridemia is Associated With Increased Insulin Resistance in Subjects assessed With the 1999 World Health Organization Criteria for the Classification of Diabetes. Metabolism: Clinical and Experimental 2003;52(5):616-19.
23. Rossetti 1990 Rossetti L, Giaccari A, Klein-Robbenhaar E, Vogel LR. Insulinomimetic properties of trace elements and characterization of their in vivo mode of action. Diabetes 1990;39:1243-50.
24. Sterne 2001 Sterne JAC, Egger M, Davey Smith G. Investigating and dealing with publication and other biases. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic Reviews in Health Care; Meta-analysis in Context. London. BMJ Publishing Group, 2001:189-208.
25. Tang 2000 Tang JL, Liu JLY. Misleading funnel plot for detection of bias in meta-analysis. Journal of Clinical Epidemiology 2000;53:477-84.
26. Thornton 2000 Thornton A, Lee P. Publication bias in meta-analysis: its causes and consequences. Journal of Clinical Epidemiology Journal of Clinical Epidemiology 2000;53:207-16 2000;53:207-16.
27. Tracey 2003 Tracey L, Mclaughlin MD, Gerald M, Reaven MD. Beyond type 2 Diabetes: The need for a clinically useful way to identify insulin resistance. The American Journal of Medicine 2003;114:501-2.
28. WHO 1997 World Health Organization. The World Health Report. WHO 1997.
29. WHO 2000 World Health Organization. Prevalence of Diabetes World Wide 2000,2030. available: http// www.who.int/diabetes/facts/world_figures/ assessed in 21 de junho de 2005.